MedPath

Loratadine

Loratadine Tablet 10 mg

Approved
Approval ID

679164cc-7505-7ed4-13fe-87f06cb777d8

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Sep 22, 2025

Manufacturers
FDA

Apotex Corp.

DUNS: 845263701

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Loratadine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code60505-0147
Application NumberANDA076471
Product Classification
M
Marketing Category
C73584
G
Generic Name
Loratadine
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 22, 2025
FDA Product Classification

INGREDIENTS (6)

LORATADINEActive
Quantity: 10 mg in 1 1
Code: 7AJO3BO7QN
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 9/26/2024

PRINCIPAL DISPLAY PANEL - 10 mg

**APOTEX CORP.**NDC 60505-0147-1

Loratadine Tablets 10 mg

Non-Drowsy*

Antihistamine/Original Prescription Strength

Compare to the active ingredient in Claritin®** Tablets**

Indoor & Outdoor Allergies

24 hour


Relief of

*Sneezing *Runny Nose *Itchy, Watery Eyes *Itchy Throat or Nose

10mg-100btl

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 2/8/2012

Uses

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

  • runny nose
  • sneezing
  • itchy, watery eyes
  • itching of the nose or throat

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 8/1/2018

Questions or comments?

Call1-800-706-5575, weekdays, 8:30 am - 5:00 pm Eastern Standard Time

Manufactured by:

Manufactured for:

Apotex Inc.

Apotex Corp.

Toronto, Ontario

Weston, Florida

Canada M9L 1T9

33326

Revised: August 2018

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 2/8/2012

Active ingredient (in each tablet)

Loratadine 10 mg

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 2/8/2012

Purpose

Antihistamine

WARNINGS SECTION

LOINC: 34071-1Updated: 2/8/2012

Warnings

Do not use if you have ever had an allergic reaction to this product or any of its ingredients.

Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.

When using this product do not take more than directed. Taking more than directed may cause drowsiness.

Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 2/8/2012

Directions

adults and children 6 years and over

1 tablet daily; not more than 1 tablet in 24 hours

children under 6 years of age

ask a doctor

consumers with liver or kidney disease

ask a doctor

STORAGE AND HANDLING SECTION

LOINC: 44425-7Updated: 8/1/2018

Other information

  • safety sealed: do not use if induction seal, with "Lift N Peel" tab, under cap is broken or missing
  • store between 2°C and 30°C (36°F and 86°F)
  • protect from excessive moisture

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 8/1/2018

Inactive ingredients

colloidal silicon dioxide, croscarmellose sodium, lactose monohydrate, magnesium stearate, microcrystalline cellulose

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.